Skip to main content

Want a detailed portfolio tracker?

Cogent Biosciences (COGT) P/E (2018 - 2026)

Cogent Biosciences (COGT) P/E from Mar 29, 2018 to Jun 12, 2026. The TTM Cogent Biosciences (COGT) P/E is -13.62. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cogent Biosciences (COGT)

YearP/EChange
2026-13.62-4.43%
2025-14.25+339.06%
2024-3.24+25.29%
2023-2.59-49.13%
2022-5.09+5.52%
2021-4.82+134.85%
2020-2.05-25.46%
2019-2.76-75.14%
2018-11.09N/A

Comparison Cogent Biosciences (COGT) P/E with competitors

Cogent Biosciences (COGT) P/E is -13.62.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Therapeutics Ltd0.13-100.95%
FGENFibroGen Inc0.24-101.76%
TRAWTraws Pharma Inc0.47-103.47%
FBIOFortress Biotech Inc0.71-105.20%
CHRSCoherus Biosciences Inc0.80-105.89%
ORMPOramed Pharmaceuticals Inc1.37-110.06%
AGENAgenus Inc1.84-113.54%
VIVSVivoSim Labs Inc2.32-117.03%
INVAInnoviva Inc3.31-124.34%
CRMDCorMedix Inc3.78-127.75%
VXRTVaxart Inc3.95-129.02%
ABEOAbeona Therapeutics Inc3.96-129.09%
SRPTSarepta Therapeutics Inc4.19-130.76%
CVACCureVac N.V.4.45-132.65%
GLPGGalapagos NV4.86-135.68%
ABUSArbutus Biopharma Corp5.06-137.13%
RIGLRigel Pharmaceuticals5.16-137.88%
CGENCompugen Ltd5.24-138.51%
ZVRAZevra Therapeutics Inc6.13-145.04%
OMEROmeros Corporation9.11-166.88%
PLXProtalix BioTherapeutics Inc9.21-167.62%
SPROSpero Therapeutics Inc9.31-168.34%
AUPHAurinia Pharmaceuticals Inc9.32-168.47%
ACADAcadia Pharmaceuticals Inc9.62-170.61%
TBPHTheravance Biopharma Inc11.86-187.07%
ADMAAdma Biologics Inc12.13-189.10%
SABSSAB Biotherapeutics Inc12.93-194.92%
HRMYHarmony Biosciences Holdings Inc14.05-203.18%
REGNRegeneron Pharmaceuticals Inc14.36-205.44%
PBYIPuma Biotechnology Inc14.45-206.15%
INCYIncyte Corp14.49-206.41%
NAGENiagen Bioscience Inc14.82-208.82%
XOMAXOMA Corp14.95-209.81%
TGTXTG Therapeutics Inc15.67-215.11%
EXELExelixis Inc16.60-221.91%
CPRXCatalyst Pharmaceuticals Inc17.36-227.46%
MDXGMimedx Group Inc17.52-228.67%
CTMXCytomX Therapeutics Inc19.63-244.15%
ASNDAscendis Pharma A/S23.50-272.59%
HALOHalozyme Therapeutics Inc23.83-274.98%
ARGXArgen X SE24.24-278.02%
XOMAOXOMA Corp25.34-286.13%
VRTXVertex Pharmaceuticals Inc25.57-287.77%
XOMAPXOMA Corp25.67-288.52%
RPRXRoyalty Pharma plc - Class A27.78-303.99%
SLNOSoleno Therapeutics Inc29.02-313.09%
LGNDLigand Pharmaceuticals Inc - Class B31.77-333.30%
APLSApellis Pharmaceuticals Inc39.02-386.57%
BMRNBiomarin Pharmaceutical Inc40.22-395.39%
KRYSKrystal Biotech Inc40.45-397.04%
ONCBeiGene Ltd58.89-532.53%
PHARPharming Group N.V.68.77-605.09%
TECHBio-Techne Corp74.88-649.96%
VCELVericel Corp87.95-745.88%
GMABGenmab118.15-967.68%
ALNYAlnylam Pharmaceuticals Inc123.07-1003.84%
TLXTelix Pharmaceuticals Ltd135.58-1095.72%
CORTCorcept Therapeutics Inc185.65-1463.41%